Neil K. Warma, President & CEO, Opexa Therapeutics, delves into Opexa’s Phase 2B ABILI-T Clinical Trial for secondary progressive multiple sclerosis (MS) that expects to yield top-line results in 2016. Previous studies showed that with…
Charlotte Collins, J.D., Senior Vice President, Policy and Programs, Asthma and Allergy Foundation of America, discusses the results from the AAFA Annual Report. According to the report, there…
Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma talks about MDX, which, if approved, will be the first therapy of its kind for Fragile X Syndrome, the orphan disease…
Yoga is often recommended to patients in order to improve their asthma symptoms but new research published in Annals of Allergy, Asthma & Immunology has shown that there is…
In a study published by The Journal of Allergy and Clinical Immunology, researchers investigated the correlation between season of birth and food allergies. The cohort consisted of African-American…
Standard digital mammography plays a key role in detecting breast cancer. However, mammography has also come under some criticism because of the false positive results it can produce,…
Chris Leamon, PhD, Vice President of Research, Endocyte, notes Endocyte’s goals for developing targeted medicines using small molecule drug conjugate platforms. Vintafolide, Endocyte’s lead product, contains a drug called…
Researchers from Mayo Clinic and other institutions have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever,…
By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – Although trastuzumab is directed against the HER2 protein, patients with HER2-negative breast cancer may also benefit from adjuvant trastuzumab therapy, researchers report. They…
